GondolaBio Service Co, Inc.
GondolaBio is seeking an experienced toxicologist with deep expertise in oligonucleotide therapeutics to provide scientific and operational leadership for nonclinical safety programs. The role involves designing and overseeing toxicology studies, managing external partners, and supporting regulatory submissions to advance clinical development. This position requires strong scientific judgment to assess human relevance and guide program decisions while maintaining patient safety.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for GondolaBio Service Co, Inc..
94% above the average for this role
Associate Director, Toxicology, Nonclinical Development (Program Toxicologist)
8a7882525b6027b0015b692822e001ab
Senior Toxicologist
Regeneron Pharmaceuticals
Principal Scientist, Toxicology
Dyne Therapeutics
Associate Director, Study Toxicologist
Madrigal Pharmaceuticals
Principal Toxicologist
Regeneron Pharmaceuticals
Director of Nonclinical Development, Toxicology
Rhythm Pharmaceuticals